AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Beta-lactam Plus Levofloxacin to Enhance Therapy in Streptococcal Septicemia

RecruitingPhase 4Ages 18 Years - anyAllMahidol University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

A double-blind randomized controlled trial comparing beta-lactam plus levofloxacin versus beta-lactam monotherapy for the treatment of Streptococcal bacteremia

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Adults age\>18 years 2. Blood culture positive for Streptococcus (\<72 hours before enrollment) * at least 1 bottle of S. pyogenes, S. agalactiae, S. pneumoniae, S. suis * at least 2 bottle of other Streptococci 3. Receiving or having plan of receiving beta-lactam therapy Exclusion Criteria: 1. Known allergy to beta-lactam or fluroquinolone antibiotics 2. Pregnancy or lactating mother 3. EKG with QT prolongation 4. Diagnosis of infective endocarditis
๐Ÿ’Š

What it tests

  • Beta-lactam monotherapy
  • Beta-lactam plus levofloxacin combination therapy
๐Ÿ“

Where

4 sites
Faculty of Medicine Siriraj Hospital
Bangkok, Thailand
Maharaj Nakorn Chiang Mai Hospital
Chiang Mai, Thailand
Maharaj Nakhon Ratchasima
Nakhon Ratchasima, Thailand
Ratchburi Hospital
Ratchaburi, Thailand
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy